Document is current
Any future updates will be listed below
-
Authors
Rauhala, Elina https://orcid.org/0000-0003-0341-2783
Johansson, Jarkko https://orcid.org/0000-0002-4501-4735
Karrasch, Mira https://orcid.org/0000-0002-6996-9157
Eskola, Olli https://orcid.org/0000-0002-9874-5662
Tolvanen, Tuula
Parkkola, Riitta https://orcid.org/0000-0001-8046-315X
Virtanen, Kirsi A.
Rinne, Juha O. https://orcid.org/0000-0001-6369-0764
-
Funding
Funding for this research was provided by:
Academy of Finland (310962)
Sigrid Juselius Foundation
Finnish State Research Funding
European Cultural Foundation
The Finnish Medicinal Foundation
Maud Kuistilan Muistosäätiö
Maire Taposen Säätiö
- License Information
-
More Information
Article History
Received: 18 May 2022
Accepted: 22 August 2022
First Online: 5 September 2022
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Hospital District of Southwest Finland on the 15th of February, 2011. Informed consent was obtained from all individual participants included in the study.
: Informed consent was obtained from all individual participants included in the study, including that imaging data can be used in research purposes and can be published in international scientific journals without possibility to identify individual participant.
: Dr. Rinne serves as an neurology consultant at CRST (Clinical Research Services Turku) and in Global Expert Panel for Novo Nordisk and in data monitoring committee in a clinical drug trial conducted by Lundbeck.
